Lifecore Biomedical Inc (LFCR)
6.98
-0.50
(-6.68%)
USD |
NASDAQ |
Nov 21, 16:00
6.975
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Enterprise Value: 379.46M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 379.46M |
| November 20, 2024 | 397.87M |
| November 19, 2024 | 383.51M |
| November 18, 2024 | 359.20M |
| November 15, 2024 | 358.10M |
| November 14, 2024 | 368.41M |
| November 13, 2024 | 383.51M |
| November 12, 2024 | 380.93M |
| November 11, 2024 | 363.25M |
| November 08, 2024 | 370.62M |
| November 07, 2024 | 357.73M |
| November 06, 2024 | 358.46M |
| November 05, 2024 | 348.34M |
| November 04, 2024 | 343.00M |
| November 01, 2024 | 338.76M |
| October 31, 2024 | 331.58M |
| October 30, 2024 | 340.60M |
| October 29, 2024 | 333.42M |
| October 28, 2024 | 329.37M |
| October 25, 2024 | 324.77M |
| October 24, 2024 | 320.90M |
| October 23, 2024 | 317.95M |
| October 22, 2024 | 315.74M |
| October 21, 2024 | 315.74M |
| October 18, 2024 | 314.27M |
| Date | Value |
|---|---|
| October 17, 2024 | 308.75M |
| October 16, 2024 | 292.18M |
| October 15, 2024 | 293.28M |
| October 14, 2024 | 292.91M |
| October 11, 2024 | 292.54M |
| October 10, 2024 | 287.57M |
| October 09, 2024 | 289.41M |
| October 08, 2024 | 299.54M |
| October 07, 2024 | 309.85M |
| October 04, 2024 | 320.53M |
| October 03, 2024 | 295.67M |
| October 02, 2024 | 275.97M |
| October 01, 2024 | 272.26M |
| September 30, 2024 | 274.73M |
| September 27, 2024 | 275.35M |
| September 26, 2024 | 268.09M |
| September 25, 2024 | 268.70M |
| September 24, 2024 | 276.42M |
| September 23, 2024 | 273.33M |
| September 20, 2024 | 276.73M |
| September 19, 2024 | 295.86M |
| September 18, 2024 | 282.90M |
| September 17, 2024 | 279.21M |
| September 16, 2024 | 279.68M |
| September 13, 2024 | 282.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
162.65M
Minimum
Mar 17 2023
567.62M
Maximum
Jun 07 2021
407.40M
Average
430.73M
Median
Enterprise Value Benchmarks
| AngioDynamics Inc | 232.21M |
| Precision Optics Corp Inc | 34.22M |
| Sage Therapeutics Inc | -272.46M |
| Outset Medical Inc | 61.50M |
| NovaBay Pharmaceuticals Inc | 2.798M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.23M |
| Revenue (Quarterly) | 24.70M |
| Total Expenses (Quarterly) | 35.81M |
| EPS Diluted (Quarterly) | -0.53 |
| Gross Profit Margin (Quarterly) | 21.81% |
| Profit Margin (Quarterly) | -65.70% |
| Earnings Yield | 0.72% |
| Normalized Earnings Yield | -12.75 |